In patients hospitalized with COVID-19, adding azithromycin to usual care did not reduce 28-d mortality
- PMID: 34058103
- DOI: 10.7326/ACPJ202106150-064
In patients hospitalized with COVID-19, adding azithromycin to usual care did not reduce 28-d mortality
Abstract
RECOVERY Collaborative Group. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397:605-12. 33545096.
Comment on
-
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.Lancet. 2021 Feb 13;397(10274):605-612. doi: 10.1016/S0140-6736(21)00149-5. Epub 2021 Feb 2. Lancet. 2021. PMID: 33545096 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources